| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥92.8B | ¥98.7B | -6.0% |
| Operating Income | ¥0.6B | ¥0.5B | +12.7% |
| Ordinary Income | ¥2.4B | ¥2.3B | +6.6% |
| Net Income | ¥1.8B | ¥1.2B | +45.0% |
| ROE | 1.8% | 1.2% | - |
FY2026 Q3 cumulative results show revenue of 9.28 billion yen (YoY -6.0%), operating income of 0.06 billion yen (YoY +12.7%), ordinary income of 0.24 billion yen (YoY +6.6%), and net income attributable to owners of parent of 0.18 billion yen (YoY +45.0%). Despite a revenue decline environment, the company maintained profitability improvement through cost management, with non-operating income from dividend receipts providing substantial support to bottom-line results. Net income growth significantly outpaced operating income expansion, driven by extraordinary gains and tax effects. The company operates exclusively in calcium carbonate manufacturing and sales as a single business segment.
Revenue declined 5.95 billion yen YoY to 92.77 billion yen, representing a -6.0% contraction, primarily reflecting reduced sales volume in the core calcium carbonate business. The company operates as a single segment focused on calcium carbonate manufacturing and sales with related ancillary services, thus revenue drivers are concentrated in this product category. Operating income increased by 0.07 billion yen to 0.55 billion yen (+12.7% YoY), indicating successful cost reduction initiatives that offset the revenue decline impact. The operating margin improved to 0.6% from 0.5% in the prior year, though remaining at a low absolute level reflecting the commodity nature of the calcium carbonate business. Ordinary income reached 2.41 billion yen (+6.6% YoY), substantially exceeding operating income by approximately 1.86 billion yen, with this differential attributable to significant non-operating income including dividend income of approximately 0.18 billion yen and foreign exchange gains representing roughly 33.6% of operating income. Net income expanded 45.0% YoY to 1.77 billion yen, with the acceleration beyond ordinary income growth driven by favorable tax effects and absence of extraordinary losses recorded in the prior period. This represents a revenue down/profit up pattern, where revenue contraction was successfully offset by operational efficiency gains and non-operating income contributions, resulting in improved profitability across all income statement levels despite top-line headwinds.
[Profitability] ROE of 1.7% represents the company's return on equity, calculated as net profit margin of 1.9% multiplied by total asset turnover of 0.543 and financial leverage of 1.67. Operating margin stands at 0.6%, reflecting the low-margin commodity nature of calcium carbonate products. Net profit margin of 1.9% indicates limited bottom-line conversion from sales. [Cash Quality] Cash and deposits totaled 30.60 billion yen with short-term debt coverage ratio of approximately 15.5 times current liabilities, indicating strong liquidity positioning. However, accounts receivable of 48.39 billion yen translates to Days Sales Outstanding of approximately 190 days, significantly elevated and indicating extended collection periods that constrain cash conversion. Cash conversion cycle extends to 181 days, combining DSO of 190 days, inventory days of approximately 21 days, and payables days of 30 days. [Investment Efficiency] Total asset turnover of 0.543 reflects moderate asset utilization efficiency. Investment securities holdings of 49.28 billion yen represent 28.9% of total assets, with other comprehensive income from securities valuation contributing to equity position. [Financial Health] Equity ratio of 60.0% (102.52 billion yen equity against 170.78 billion yen total assets) demonstrates solid capital adequacy. Current ratio of 273.2% and quick ratio of 256.0% confirm robust short-term solvency. Interest-bearing debt of 19.72 billion yen results in debt-to-equity ratio of 0.19 and debt-to-capital ratio of 16.1%, indicating conservative leverage positioning.
Cash and deposits increased 2.22 billion yen YoY from 28.38 billion yen to 30.60 billion yen, representing a 7.8% growth in cash position that reflects cumulative operating profitability despite revenue contraction. The improvement in net income to 1.77 billion yen provided the primary source of cash accumulation, with non-cash items including securities valuation gains also contributing to comprehensive income of 3.10 billion yen. Working capital dynamics show accounts receivable increased 2.14 billion yen YoY to 48.39 billion yen, indicating extended customer credit terms that absorb substantial operating cash. Inventory decreased marginally by 0.09 billion yen to 5.30 billion yen, suggesting inventory management remained relatively stable. Accounts payable decreased 1.02 billion yen to 7.81 billion yen, representing reduced supplier credit utilization that consumed operating cash. Investment securities increased 2.02 billion yen to 49.28 billion yen, suggesting continued capital allocation toward financial assets. Long-term borrowings remained stable at 19.72 billion yen, indicating no material debt financing activity during the period. The cash coverage ratio against current liabilities of 30.93 billion yen stands at 0.99 times, though when combined with marketable securities and short-term receivables in current assets of 84.48 billion yen, overall liquidity coverage reaches 2.73 times, demonstrating adequate near-term payment capacity despite working capital efficiency concerns around extended receivables collection.
Ordinary income of 2.41 billion yen versus operating income of 0.55 billion yen indicates non-operating net contribution of approximately 1.86 billion yen, representing 338% of operating income and 2.0% of revenue. This substantial non-operating contribution comprises primarily dividend income from investment securities holdings of 0.18 billion yen and foreign exchange gains that fluctuate with currency movements, with FX gains estimated at approximately 0.18 billion yen based on the reported FX impact ratio of 33.6% relative to operating income. Non-operating income represents 2.0% of total revenue, consisting predominantly of financial income from the company's 49.28 billion yen investment securities portfolio. The reliance on non-operating income sources introduces earnings volatility dependent on market conditions and FX movements rather than core operational performance. Net income of 1.77 billion yen reflects ordinary income adjusted for extraordinary items and tax effects, with the effective tax burden and absence of prior-year extraordinary losses contributing to the 45.0% YoY net income growth exceeding the 6.6% ordinary income growth. The extended DSO of 190 days and cash conversion cycle of 181 days suggest potential accruals buildup in accounts receivable that may not convert to cash proportionately, warranting attention to earnings quality from a cash realization perspective. The substantial contribution of securities holdings to comprehensive income through valuation gains and dividend income indicates earnings composition tilted toward financial assets rather than purely operational performance, with operating margin of only 0.6% highlighting limited core business profitability and high dependency on investment portfolio returns for overall earnings sustainability.
Extended receivables collection period with DSO of approximately 190 days creates significant working capital strain and exposes the company to customer credit risk and potential bad debt losses, particularly if customer financial conditions deteriorate. The 48.39 billion yen accounts receivable balance represents 52% of revenue, indicating concentration of capital in uncollected sales that limits cash availability for operations and investments.
Heavy reliance on non-operating income with 1.86 billion yen contribution (338% of operating income) from dividend income and foreign exchange gains introduces earnings volatility and dependency on factors outside management control, including equity market performance, interest rate movements, and currency fluctuations. Operating margin of only 0.6% indicates insufficient core business profitability to sustain earnings without investment portfolio contributions.
Commodity pricing pressure in calcium carbonate business with gross profit margin of 17.5% below industry benchmarks of approximately 20% limits pricing power and profit margin expansion potential, exposing the company to competitive intensity and raw material cost inflation that cannot be fully passed through to customers. Single segment concentration in calcium carbonate manufacturing amplifies exposure to product-specific demand cycles and substitution risks.
[Industry Position] (Reference - Proprietary Analysis)
Profitability metrics show Maruo Calcium's operating margin of 0.6% significantly underperforms the manufacturing industry median of 8.3% (IQR: 4.8%-12.6%), indicating substantial operational efficiency challenges relative to peers. Net profit margin of 1.9% also trails the industry median of 6.3% (IQR: 3.2%-9.0%), reflecting both operational and structural profitability constraints. ROE of 1.7% falls well below the industry median of 5.0% (IQR: 2.9%-8.1%), positioning in the bottom quartile for capital efficiency. ROA of 1.0% underperforms the industry median of 3.3% (IQR: 1.8%-5.2%), confirming weak asset productivity. Financial health indicators present a more favorable picture, with equity ratio of 60.0% slightly below the industry median of 63.8% (IQR: 49.5%-74.7%) but remaining within healthy parameters. Current ratio of 273.2% substantially exceeds the industry median of 2.84 times (IQR: 2.10-3.81), indicating exceptional liquidity positioning. Efficiency metrics reveal significant operational challenges, with receivables turnover of approximately 190 days dramatically exceeding the industry median of 82.87 days (IQR: 68.43-115.00 days), placing the company in the bottom decile for collection efficiency. Asset turnover of 0.543 underperforms the industry median of 0.58 (IQR: 0.42-0.66), though the gap is less pronounced. Revenue growth of -6.0% compares unfavorably to the industry median of +2.7% (IQR: -1.9% to +7.9%), indicating market share losses or end-market weakness. The company's operational performance lags manufacturing sector peers substantially in profitability and efficiency dimensions, while maintaining superior liquidity and adequate capital structure positioning.
※ Industry: Manufacturing Sector (98 companies for most metrics), Comparison: 2025-Q3 fiscal period, Source: Proprietary analysis
Key observations from the FY2026 Q3 earnings data reveal a company navigating revenue contraction while maintaining profitability through cost discipline and investment income contributions. Operating performance remains challenged with a 0.6% operating margin substantially below industry standards, indicating limited pricing power and operational efficiency in the commodity calcium carbonate business. The 1.86 billion yen non-operating income contribution, representing 338% of operating income, highlights structural dependency on investment securities portfolio returns and foreign exchange gains rather than core business strength, introducing earnings volatility tied to financial market conditions. Working capital management presents the most critical operational concern, with DSO extending to 190 days compared to an industry median near 83 days, absorbing substantial capital in uncollected receivables that constrains cash generation despite reported profitability. The 60.0% equity ratio and 273% current ratio demonstrate conservative financial positioning with ample liquidity buffers, though the 1.7% ROE indicates capital deployment efficiency requires improvement to generate adequate shareholder returns. Revenue declining 6.0% against an industry median growth of 2.7% suggests competitive positioning challenges or end-market weakness that may persist absent strategic initiatives to enhance value proposition or expand addressable markets. The combination of operational margin compression, extended working capital cycles, and dependency on non-operating income sources indicates the need for fundamental business model improvements including customer credit policy tightening, operational efficiency enhancement, and core business margin expansion to achieve sustainable earnings growth independent of financial asset performance.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.